New hope for Hard-to-Treat brain cancer: targeted radiation trial launches
Disease control
Recruiting now
This early-phase study tests a new drug called [90Y]Y-PentixaTher for people with central nervous system (CNS) lymphoma that has come back or not responded to standard treatments. The drug delivers radiation directly to cancer cells. About 15 participants will receive one intrave…
Phase: PHASE1, PHASE2 • Sponsor: Pentixapharm AG • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC